109 related articles for article (PubMed ID: 18789393)
21. A phase I clinical study of inhaled nitric oxide in healthy adults.
Miller C; Miller M; McMullin B; Regev G; Serghides L; Kain K; Road J; Av-Gay Y
J Cyst Fibros; 2012 Jul; 11(4):324-31. PubMed ID: 22520076
[TBL] [Abstract][Full Text] [Related]
22. Dual action antimicrobial surfaces via combined nitric oxide and silver release.
Storm WL; Johnson JA; Worley BV; Slomberg DL; Schoenfisch MH
J Biomed Mater Res A; 2015 Jun; 103(6):1974-84. PubMed ID: 25205657
[TBL] [Abstract][Full Text] [Related]
23. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn: four-year experience in a single medical center.
Su BH; Lin TW; Lin HC; Tsai FJ; Peng CT
Acta Paediatr Taiwan; 2002; 43(5):259-64. PubMed ID: 12607481
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of biocidal properties of silver nanoparticles against cariogenic bacteria].
Pokrowiecki R; Zareba T; Mielczarek A; Opalińska A; Wojnarowicz J; Majkowski M; Lojkowski W; Tyski S
Med Dosw Mikrobiol; 2013; 65(3):197-206. PubMed ID: 24432559
[TBL] [Abstract][Full Text] [Related]
25. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa].
Feng P; Yu R; Xia P; Lü X; Zhu S
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices.
Jones ML; Ganopolsky JG; Labbé A; Wahl C; Prakash S
Appl Microbiol Biotechnol; 2010 Sep; 88(2):401-7. PubMed ID: 20680266
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes.
Li F; Feterl M; Mulyana Y; Warner JM; Collins JG; Keene FR
J Antimicrob Chemother; 2012 Nov; 67(11):2686-95. PubMed ID: 22865383
[TBL] [Abstract][Full Text] [Related]
29. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
30. [Incidence and sensitivity to antibiotics of germs isolated from surgical wound infections].
Berceanu Văduva D; Moldovan R; Dumitraşcu V; Muntean D; Bădiţoiu L; Licker M; Crăciunescu M; Dan L; Branea D; Hogea E; Amăricăi E; Horhat F; Grigoraş D; Popa M; Berceanu Văduva M
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):123-9. PubMed ID: 15341326
[TBL] [Abstract][Full Text] [Related]
31. A Randomized, Multicenter, Blinded Pilot Study Assessing the Effects of Gaseous Nitric Oxide in an Ex Vivo System of Human Lungs.
Hartwig MG; Klapper JA; Poola N; Banga A; Sanchez PG; Murala JS; Potenziano JL
Pulm Ther; 2023 Mar; 9(1):151-163. PubMed ID: 36510099
[TBL] [Abstract][Full Text] [Related]
32. Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates.
Weinberger B; Fakhrzadeh L; Heck DE; Laskin JD; Gardner CR; Laskin DL
Am J Respir Crit Care Med; 1998 Sep; 158(3):931-8. PubMed ID: 9731028
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of bactericidal effect of three antiseptics on bacteria isolated from wounds.
Kumara DU; Fernando SS; Kottahachchi J; Dissanayake DM; Athukorala GI; Chandrasiri NS; Damayanthi KW; Hemarathne MH; Pathirana AA
J Wound Care; 2015 Jan; 24(1):5-10. PubMed ID: 25543818
[TBL] [Abstract][Full Text] [Related]
34. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
[TBL] [Abstract][Full Text] [Related]
35. Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2).
Feng Y; Huang N; Wu Q; Bao L; Wang BY
Acta Pharmacol Sin; 2005 Sep; 26(9):1087-92. PubMed ID: 16115376
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing.
Weller RB
J Invest Dermatol; 2009 Oct; 129(10):2335-7. PubMed ID: 19749782
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports.
Cushnie TP; Hamilton VE; Lamb AJ
Microbiol Res; 2003; 158(4):281-9. PubMed ID: 14717448
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection.
Martinez LR; Han G; Chacko M; Mihu MR; Jacobson M; Gialanella P; Friedman AJ; Nosanchuk JD; Friedman JM
J Invest Dermatol; 2009 Oct; 129(10):2463-9. PubMed ID: 19387479
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial efficacy of silver ions in combination with tea tree oil against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans.
Low WL; Martin C; Hill DJ; Kenward MA
Int J Antimicrob Agents; 2011 Feb; 37(2):162-5. PubMed ID: 21163626
[TBL] [Abstract][Full Text] [Related]
40. Colloidal silver as an antimicrobial agent: fact or fiction?
van Hasselt P; Gashe BA; Ahmad J
J Wound Care; 2004 Apr; 13(4):154-5. PubMed ID: 15114827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
